Evidence 1
Activity
Activity
11.84±0.46% Hemolysis
Toxicity
100 µM
Hemolytic
Cytotoxic
11.84±0.46% Hemolysis | 100 | µM | target cell: Human erythrocytes
Target
Human erythrocytes
Source & Reference
NA
DBAASP
A potent antibacterial activity of new short d-enantiomeric lipopeptide against multi drug resistant bacteria. | Biochim Biophys Acta | 2019